Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 61.43% vs 30.21% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 478.73% vs -15.30% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 16,700.00% vs -107.08% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 10.45% vs 4.15% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Alnylam Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 61.43% vs 30.21% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 149.35% vs -33.26% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 478.73% vs -15.30% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 325.00% vs -175.51% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 16,700.00% vs -107.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 707.00% vs -127.68% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 10.45% vs 4.15% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 29.07% vs 11.33% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






